IMpassion050: A phase III study of neoadjuvant atezolizumab + pertuzumab + trastuzumab + chemotherapy (neoadj A + PH + CT) in high-risk, HER2-positive early breast cancer (EBC) Meeting Abstract


Authors: Huober, J.; Barrios, C. H.; Niikura, N.; Jarzab, M.; Chang, Y. C.; Huggins-Puhalla, S. L.; Graupner, V.; Eiger, D.; Henschel, V.; Gochitashvili, N.; Lambertini, C.; Restuccia, E.; Zhang, H.
Abstract Title: IMpassion050: A phase III study of neoadjuvant atezolizumab + pertuzumab + trastuzumab + chemotherapy (neoadj A + PH + CT) in high-risk, HER2-positive early breast cancer (EBC)
Meeting Title: ESMO Virtual Plenary
Journal Title: Annals of Oncology
Volume: 32
Issue: 8
Meeting Dates: 2021 Jun 17-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-08-01
Start Page: 1061
End Page: 1062
Language: English
ACCESSION: WOS:000761584200002
DOI: 10.1016/j.annonc.2021.05.800
PROVIDER: wos
Notes: Meeting Abstract: VP6-2021 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Hong Zhang
    54 Zhang